Emmecell   Report issue

For profit Phase 1
Founded: North Fair Oaks CA United States (2015)

Organization Overview

First Clinical Trial
2016
NCT04191629
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Emmecell